marketcaparena

XBIO

Xenetic Biosciences, Inc.

Company overview

Market capitalization
$5.46M
Employees
2
Latest publication
2026-09-29
About Xenetic Biosciences, Inc.

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing immune-oncology technologies to treat cancers. Its DNase technology targets neutrophil extracellular traps (NETS), which are involved in cancer growth, metastasis, and progression, and contribute to immunotherapy, chemotherapy, and radiotherapy resistance. The company's product pipeline includes XBIO-015 for the treatment of pancreatic carcinoma and solid tumors; XBIO-020 for the treatment of solid tumors; and ErepoXen, which uses PolyXen platform technology for the treatment of anemia in chronic kidney disease (CKD) patients. It has a sublicensing agreement with Takeda Pharmaceutical Co. Ltd, as well as various research, development, license and supply agreements with Serum Institute of India, PJSC Pharmsynthez, and SynBio, LLC. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
Total Revenue660,601USD806,923USD766,296USD1,026,956USD589,897USD593,261USD648,820USD614,243USD
Research Development552,013USD661,443USD773,416USD756,482USD656,557USD879,029USD1,042,255USD367,985USD
General And Administrative Expenses1,080,278USD———————
Total Operating Expenses1,632,291USD1,309,040USD1,389,323USD1,571,690USD1,314,309USD1,535,670USD1,747,965USD1,113,716USD
Operating Income-971,690USD-502,117USD-623,027USD-544,734USD-724,412USD-942,409USD-1,099,145USD-499,473USD
Total Other Income Expense Net41,995USD45,735USD43,951USD34,795USD35,709USD39,268USD44,624USD62,802USD
Interest Income42,067USD45,756USD43,792USD30,783USD34,232USD39,190USD51,867USD61,298USD
Net Income-929,695USD-456,382USD-579,076USD-509,939USD-688,703USD-903,141USD-1,054,521USD-436,671USD
Gross Profit—806,923USD766,296USD1,026,956USD589,897USD593,261USD648,820USD614,243USD
Selling General Administrative—647,597USD615,907USD815,209USD657,752USD656,641USD705,710USD745,731USD
Net Interest Income—45,756USD43,792USD30,783USD34,232USD39,190USD51,867USD61,298USD
Income Before Tax—-456,382USD-579,076USD-509,939USD-688,703USD-903,141USD-1,054,521USD-436,671USD
Net Income From Continuing Ops—-456,382USD-579,076USD-509,940USD-688,703USD-903,141USD-1,054,521USD-436,671USD
Ebitda—-502,117USD-623,027USD-523,176USD-724,412USD-942,409USD-1,099,145USD-499,473USD
Ebit———-509,939USD—-1,109,769USD——
Depreciation And Amortization———-13,237USD—10,624USD——
Income Tax Expense—————-10,624USD—-436,671USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Revenue2,976,411USD2,500,284USD2,539,986USD1,706,925USD1,160,692USD436,942USD17,066USD0USD
Gross Profit2,976,411USD2,500,284USD2,539,986USD1,706,925USD1,160,692USD436,942USD17,066USD-15,827USD
Research Development3,065,484USD3,288,332USD3,494,765USD4,770,834USD3,163,485USD1,731,406USD4,889,340USD2,883,952USD
Selling General Administrative2,745,509USD3,416,380USD3,560,936USD3,653,999USD3,743,972USD3,400,071USD4,731,176USD4,392,375USD
Total Operating Expenses5,810,993USD6,704,712USD7,055,701USD8,424,833USD6,907,457USD14,374,605USD12,903,895USD7,276,327USD
Operating Income-2,834,582USD-4,204,428USD-4,515,715USD-6,717,908USD-5,746,765USD-13,937,663USD-12,886,829USD-7,276,327USD
Interest Income147,997USD249,861USD351,807USD167,152USD100,467USD126,171USD108,490USD510USD
Net Interest Income147,997USD249,861USD351,807USD167,152USD100,467USD126,171USD108,489USD509USD
Income Before Tax-2,680,860USD-3,960,275USD-4,134,578USD-6,552,353USD-5,645,179USD-13,811,984USD-12,775,025USD-7,300,458USD
Net Income-2,680,860USD-3,960,275USD-4,134,578USD-6,552,353USD-5,645,179USD-10,893,466USD-12,775,025USD-7,300,458USD
Net Income From Continuing Ops-2,680,860USD-3,960,275USD-4,445,607USD-6,552,353USD-5,645,179USD-10,893,466USD-12,775,025USD-7,300,458USD
Ebitda-2,834,582USD-4,051,092USD-4,515,715USD-6,690,865USD-5,711,283USD-4,665,698USD-9,575,963USD-7,260,500USD
Total Other Income Expense Net153,722USD244,153USD381,137USD165,555USD101,586USD125,679USD111,804USD-24,131USD
Ebit—-4,204,428USD-4,487,792USD-6,717,908USD-5,746,765USD-4,694,535USD-9,603,450USD-7,276,327USD
Depreciation And Amortization—153,336USD-28,208USD27,043USD35,482USD28,837USD27,487USD15,827USD
Income Tax Expense——28,207USD-165,555USD-100,467USD-2,918,518USD3,174,890USD24,131USD
Reconciled Depreciation——0USD27,043USD35,482USD28,837USD27,487USD15,827USD
Cost Of Revenue———27,043USD35,482USD——15,827USD
Interest Expense———165,555USD101,586USD18,360,577USD111,804USD24,131USD
Tax Provision————0USD-2,918,518USD——
Net Income Applicable To Common Shares————-5,645,179USD-10,893,466USD-18,059,404USD-7,300,458USD
Unclassified Operating Expenses—————9,243,128USD3,283,379USD—
Non Operating Income Net Other—————-492USD3,315USD-24,640USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
Total Assets6,967,998USD7,908,991USD8,363,847USD5,067,960USD5,353,700USD5,791,217USD6,901,443USD8,046,000USD
Cash And Equivalents6,471,766USD———————
Total Current Assets6,654,077USD7,595,070USD8,049,926USD5,067,960USD5,353,700USD5,477,296USD6,587,522USD7,027,648USD
Other Current Assets182,311USD247,815USD166,294USD946,361USD573,854USD313,620USD421,954USD188,088USD
Other Non Current Assets313,921USD———————
Total Liabilities894,977USD———————
Total Current Liabilities894,977USD958,239USD968,025USD1,111,775USD903,430USD667,927USD894,263USD1,009,407USD
Total Stockholder Equity6,073,021USD6,950,752USD7,395,822USD3,956,185USD4,450,270USD5,123,290USD6,007,180USD7,036,593USD
Total Equity Including Noncontrolling Interest6,073,021USD———————
Accounts Payable322,537USD558,808USD258,109USD578,250USD346,828USD240,293USD283,615USD243,343USD
Common Stock2,346USD2,294USD2,294USD1,545USD1,545USD1,545USD1,545USD1,545USD
Retained Earnings-201,261,408USD-200,331,713USD-199,875,331USD-199,296,255USD-198,786,315USD-198,097,612USD-197,194,471USD-196,139,950USD
Accumulated Other Comprehensive Income253,734USD253,734USD253,734USD253,734USD253,734USD253,734USD253,734USD253,734USD
Total Liab—958,239USD968,025USD1,111,775USD903,430USD667,927USD894,263USD1,009,407USD
Other Current Liab—399,431USD709,916USD533,525USD556,602USD427,634USD610,648USD766,064USD
Capital Stock—3,748USD3,748USD3,349USD3,349USD3,349USD3,349USD3,349USD
Cash—7,347,255USD7,883,632USD4,121,599USD4,779,846USD5,163,676USD6,165,568USD6,839,560USD
Cash And Short Term Investments—7,347,255USD7,883,632USD4,121,599USD4,779,846USD5,163,676USD6,165,568USD6,839,560USD
Net Debt—-7,347,255USD-7,883,632USD-4,121,599USD-4,779,846USD-5,163,676USD-6,165,568USD-6,839,560USD
Common Stock Shares Outstanding—2,291,056shares2,291,056shares1,542,139shares1,542,139shares1,542,139shares1,541,339shares1,541,722shares
Non Current Assets Total—313,921USD313,921USD0USD0USD313,921USD313,921USD1,018,352USD
Non Current Liabilities Total—0USD0USD0USD0USD0USD0USD0USD
Non Currrent Assets Other—313,921USD313,921USD——313,921USD313,921USD1,018,352USD
Net Working Capital—6,636,831USD7,081,901USD3,956,185USD4,450,270USD4,809,369USD5,693,259USD6,018,241USD
Unclassified Equity—207,022,689USD207,011,377USD202,993,812USD202,977,957USD202,962,274USD202,943,023USD202,917,915USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Assets8,363,847USD6,901,443USD10,605,226USD14,720,290USD19,815,360USD13,179,495USD21,546,926USD14,431,094USD
Other Current Assets166,294USD421,954USD603,828USD556,094USD479,399USD841,958USD722,079USD622,366USD
Total Liab968,025USD894,263USD809,585USD1,073,156USD1,421,103USD963,971USD4,333,675USD4,518,306USD
Total Stockholder Equity7,395,822USD6,007,180USD9,795,641USD13,647,134USD18,394,257USD12,215,524USD17,213,251USD9,912,788USD
Other Current Liab709,916USD610,648USD568,753USD785,796USD1,031,590USD574,050USD463,987USD665,641USD
Common Stock2,294USD1,545USD1,544USD1,520USD13,465USD8,771USD6,092USD9,726USD
Capital Stock3,748USD3,349USD3,348USD17,966USD16,239USD11,545USD8,866USD12,500USD
Retained Earnings-199,875,331USD-197,194,471USD-193,234,196USD-189,099,618USD-182,547,265USD-176,902,086USD-166,008,620USD-153,233,595USD
Cash7,883,632USD6,165,568USD8,983,046USD13,097,265USD18,244,030USD11,527,552USD10,367,920USD571,605USD
Cash And Short Term Investments7,883,632USD6,165,568USD8,983,046USD13,097,265USD18,244,030USD11,527,552USD10,367,920USD571,605USD
Total Current Assets8,049,926USD6,587,522USD9,586,874USD13,653,359USD18,723,429USD12,369,510USD11,089,999USD1,193,971USD
Total Current Liabilities968,025USD894,263USD809,585USD1,073,156USD1,421,103USD936,928USD1,415,157USD1,599,788USD
Net Debt-7,883,632USD-6,165,568USD-8,983,046USD-13,097,265USD-18,216,987USD-11,465,027USD-10,347,878USD-571,605USD
Accounts Payable258,109USD283,615USD240,832USD287,360USD362,470USD327,396USD931,128USD934,147USD
Accumulated Other Comprehensive Income253,734USD253,734USD253,734USD253,734USD253,734USD253,734USD253,734USD253,734USD
Common Stock Shares Outstanding1,701,571shares1,541,339shares1,528,210shares1,422,443shares1,027,940shares639,238shares285,246shares75,601shares
Non Current Assets Total313,921USD313,921USD1,018,352USD1,066,931USD1,091,931USD809,985USD10,456,926USD13,237,123USD
Non Current Liabilities Total0USD0USD0USD287,360USD362,470USD27,043USD2,918,518USD2,918,518USD
Non Currrent Assets Other313,921USD313,921USD1,018,352USD1,066,931USD1,091,931USD782,942USD1,192,999USD705,660USD
Net Working Capital7,081,901USD5,693,259USD8,777,289USD12,580,203USD17,302,326USD11,432,582USD9,674,842USD-405,817USD
Unclassified Equity207,011,377USD202,943,023USD202,771,211USD202,473,532USD200,658,084USD194,124,740USD188,234,359USD168,151,603USD
Other Assets————1,091,931USD809,985USD1,213,042USD705,660USD
Current Deferred Revenue————-27,043USD-35,482USD-20,042USD—
Short Term Debt————27,043USD35,482USD20,042USD—
Short Long Term Debt Total————27,043USD62,525USD20,042USD—
Property Plant Equipment Net————0USD27,043USD20,799USD4,956USD
Property Plant Equipment Gross————50,243USD57,027USD57,027USD—
Net Tangible Assets————18,391,483USD12,212,750USD7,967,349USD-2,616,493USD
Unclassified Non Current Assets————-1,091,931USD—-10,456,170USD—
Deferred Long Term Liab—————27,043USD2,918,518USD2,918,518USD
Other Liab—————27,043USD2,918,518USD2,918,518USD
Good Will—————0USD9,243,128USD3,283,379USD
Net Receivables—————500,000USD——
Treasury Stock—————-5,281,180USD-5,281,180USD-5,281,180USD
Non Current Liabilities Other—————27,043USD——
Intangible Assets——————9,243,128USD9,243,128USD
Unclassified Non Current Liabilities——————-2,918,518USD-2,918,518USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Net Income-456,382USD-579,076USD-509,939USD-688,703USD-903,141USD-1,054,521USD-436,671USD-1,273,970USD
Stock Based Compensation11,312USD13,998USD15,855USD15,683USD19,251USD25,108USD27,536USD42,096USD
Other Non Cash Items11,312USD322,396USD15,854USD171,190USD19,251USD—615,562USD-829,012USD
Change In Working Capital-91,307USD322,396USD-164,162USD289,190USD-118,002USD355,421USD-49,902USD706,770USD
Total Cash From Operating Activities-536,377USD-242,682USD-658,247USD-383,830USD-1,001,892USD-673,992USD-459,037USD-525,104USD
Capital Expenditures-3USD0USD-3USD0USD-2USD0USD0USD0USD
Free Cash Flow-536,380USD-242,682USD-658,250USD-383,830USD-1,001,890USD-673,992USD-459,037USD-525,104USD
Change In Cash-536,377USD3,762,033USD-658,247USD-383,830USD-1,001,892USD-673,992USD-459,037USD-525,104USD
Begin Period Cash Flow7,883,632USD4,121,599USD4,779,846USD5,163,676USD6,165,568USD6,839,560USD7,298,597USD7,823,701USD
End Period Cash Flow7,347,255USD7,883,632USD4,121,599USD4,779,846USD5,163,676USD6,165,568USD6,839,560USD7,298,597USD
Total Cash From Financing Activities—4,004,715USD——————
Other Cashflows From Financing Activities—4,004,715USD——————
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Net Income-2,680,860USD-3,960,275USD-4,134,578USD-6,552,353USD-5,645,179USD-10,893,466USD-12,775,025USD-7,300,458USD
Stock Based Compensation64,787USD171,814USD283,085USD511,480USD410,437USD468,914USD853,517USD1,421,581USD
Other Non Cash Items329,422USD970,983USD283,085USD1,793,750USD24,269USD9,099,489USD6,376,141USD-5,231USD
Change In Working Capital329,422USD970,983USD-262,726USD-426,685USD461,193USD-52,449USD-881,524USD-595,676USD
Total Cash From Operating Activities-2,286,651USD-2,817,478USD-4,114,219USD-4,646,765USD-4,738,067USD-4,267,193USD-6,399,404USD-6,463,957USD
Capital Expenditures0USD0USD-1USD-500,000USD0USD0USD0USD0USD
Free Cash Flow-2,286,651USD-2,817,478USD-4,114,220USD-5,146,765USD-4,738,067USD-4,267,193USD-6,399,404USD-6,463,957USD
Total Cash From Financing Activities4,004,715USD1USD16USD1,293,750USD11,454,545USD5,426,825USD16,127,209USD1,480,000USD
Issuance Of Capital Stock4,004,715USD1USD—0USD11,450,866USD5,426,825USD16,121,000USD—
Change In Cash1,718,064USD-2,817,478USD-4,114,219USD-5,146,765USD6,716,478USD1,159,632USD9,729,805USD-4,961,457USD
Begin Period Cash Flow6,165,568USD8,983,046USD13,097,265USD18,244,030USD11,527,552USD10,367,920USD638,115USD5,599,572USD
End Period Cash Flow7,883,632USD6,165,568USD8,983,046USD13,097,265USD18,244,030USD11,527,552USD10,367,920USD638,115USD
Other Cashflows From Financing Activities4,004,715USD—-16USD-500,000USD3,679USD5,426,825USD6,209USD1,480,000USD
Unclassified Financing Cash Flow-4,004,715USD————-5,426,825USD13,089,774USD-1,480,000USD
Depreciation——0USD27,043USD35,482USD28,837USD27,487USD15,827USD
Investments——0USD-500,000USD0USD0USD2,000USD22,500USD
Total Cashflows From Investing Activities———-500,000USD——2,000USD22,500USD
Sale Purchase Of Stock———1,293,750USD—5,426,825USD3,031,226USD1,480,000USD
Other Cashflows From Investing Activities———500,000USD——2,000USD22,500USD
Change To Liabilities————457,132USD-378,111USD-227,961USD-343,878USD
Cash And Cash Equivalents Changes—————1,159,632USD9,729,805USD-4,961,457USD
Unclassified Operating Cash Flow—————-2,918,518USD——
Change To Account Receivables———————0USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

PeriodDimensionBusiness / regionRevenueCurrencySource
FY 2019Yearly · 2019-12-31ProductCodevelopment Agr0USD0001683168-20-000967
FY 2019Yearly · 2019-12-31ProductRoyalty17,066USD0001683168-20-000967
FY 2019Yearly · 2019-12-31ProductRoyalty Revenue0USD0001683168-20-000967
FY 2017Yearly · 2017-12-31ProductCodevelopment Agr0USD0001683168-19-000840
FY 2017Yearly · 2017-12-31ProductLicense7,500,000USD0001683168-19-000840
FY 2017Yearly · 2017-12-31ProductRoyalty Revenue0USD0001683168-19-000840
FY 2017Yearly · 2017-12-31ProductServices85,000USD0001683168-19-000840

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.